Methods for the diagnosis and pro- gnosis of Alzheimer's disease

Details for Australian Patent Application No. 2004249919 (hide)

Owner Aventis Pharma S.A.

Inventors Pradier, Laurent; Mace, Sandrine; Benavides, Jesus; Ricard, Sylvain; Cousin, Emmanuelle; Deleuze, JeanFrancois

Agent Watermark

Pub. Number AU-B-2004249919

PCT Pub. Number WO2004/113568

Priority 03 07501 20.06.03 FR

Filing date 17 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 13 August 2009

International Classifications

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/113568 Priority application(s): WO2004/113568

13 August 2009 Application Accepted

  Published as AU-B-2004249919

10 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249920-Method for hydroentangling a nonwoven fibrous web and a web of this type

2004249904-New biological entities and the pharma- ceutical or diagnostic use thereof